BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19897978)

  • 1. Diagnostic standards in the pathology of inflammatory bowel disease.
    Loddenkemper C
    Dig Dis; 2009; 27(4):576-83. PubMed ID: 19897978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
    Vucelic B
    Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic difficulties in inflammatory bowel disease pathology.
    Yantiss RK; Odze RD
    Histopathology; 2006 Jan; 48(2):116-32. PubMed ID: 16405661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant transformation in inflammatory bowel disease: prevention, surveillance and treatment - new techniques in endoscopy.
    Bojarski C
    Dig Dis; 2009; 27(4):571-5. PubMed ID: 19897977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dysplasia in ulcerative colitis].
    Werner M; Mueller E
    Verh Dtsch Ges Pathol; 1999; 83():122-9. PubMed ID: 10714202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Premalignant and malignant changes in idiopathic inflammatory bowel disease].
    Knezević-Usaj S; Panisić M; Tarabar D; Cuk V; Brajuković G; Petrović M
    Acta Chir Iugosl; 2000; 47(1-2):43-50. PubMed ID: 10953365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopy/surveillance in inflammatory bowel disease.
    Ahmadi AA; Polyak S
    Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Bansi DS; Chapman RW; Fleming KA
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologic markers in inflammatory bowel disease (IBD).
    Nakamura RM; Barry M
    MLO Med Lab Obs; 2001 Nov; 33(11):8-15; quiz 16-9. PubMed ID: 11721286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer in inflammatory bowel disease.
    Greenstein AJ
    Mt Sinai J Med; 2000 May; 67(3):227-40. PubMed ID: 10828908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and pattern of indeterminate colitis: Crohn's disease with ulcerative colitis-like clinical presentation.
    Matsui T; Yao T; Sakurai T; Yao K; Hirai F; Matake H; Tsuda S; Wada Y; Iwashita A; Kamachi S
    J Gastroenterol; 2003; 38(7):647-55. PubMed ID: 12898357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomas.
    Wong NA; Herbst H; Herrmann K; Kirchner T; Krajewski AS; Moorghen M; Niedobitek F; Rooney N; Shepherd NA; Niedobitek G
    J Pathol; 2003 Oct; 201(2):312-8. PubMed ID: 14517849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving endoscopic technologies for the detection of dysplasia in inflammatory bowel diseases.
    Buda A; Lamboglia F; Hatem G; D'Incà R; Sturniolo GC
    Ann Ital Chir; 2011; 82(1):29-35. PubMed ID: 21657152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel diseases].
    Pytrus T; Mowszet K; Krzesiek E; Rzeszutko M; Iwańczak B
    Pol Merkur Lekarski; 2008 Dec; 25(150):460-4. PubMed ID: 19205374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.